BCLI
BRAINSTORM CELL THERAPEUTICS INC.
-0.02 (-2.04%)0.96USD2.0K成交股數10.6M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 963K | 762K | 852K | 899K | 1.1M | 1.3M | 1.0M | 922K | 961K | 1.7M | 3.3M | 2.8M |
| 銷售管理費用 | 2.7M | 1.3M | 1.4M | 1.1M | 1.5M | 1.8M | 2.0M | 2.1M | 1.5M | 3.1M | 2.7M | 2.7M |
| 營業利益 | −3.6M+40% | −2.0M-34% | −2.2M-26% | −2.0M-31% | −2.6M+4% | −3.1M-36% | −3.0M-49% | −3.0M-45% | −2.5M | −4.8M | −6.0M | −5.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.9M+33% | −2.1M-26% | −2.4M-10% | −2.1M-17% | −2.9M-15% | −2.9M-49% | −2.7M+121% | −2.5M-52% | −3.4M | −5.6M | −1.2M | −5.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.35+3% | -0.19-58% | -0.13-75% | -0.19-68% | -0.34-55% | -0.45-91% | -0.51+13% | -0.60+362% | -0.75 | -5.28 | -0.45 | -0.13 |
| 稀釋股數 | 11.0M | 11.0M | 9.3M | 11.0M | 8.6M | 6.3M | 5.3M | 4.7M | 4.3M | 2.9M | 3.0M | 39.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 22K | 15K | 29K | 5K | 824K | 1.6M | 168K | 3.5M | 779K | 1.3M | 1.2M | 546K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 788K | 755K | 1.0M | 1.4M | 2.6M | 3.6M | 2.0M | 5.7M | 3.3M | 4.2M | 5.7M | 5.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 12.4M | 11.8M | 11.0M | 9.1M | 8.6M | 11.0M | 8.1M | 9.2M | 8.9M | 9.1M | 8.3M | 9.6M |
| 股東權益 | −11.6M | −11.0M | −10.0M | −7.7M | −6.1M | −7.5M | −6.1M | −3.5M | −5.6M | −4.9M | −2.6M | −3.9M |
| 負債比 | 1,571.7% | 1,558.1% | 1,077.0% | 657.5% | 336.0% | 308.8% | 399.1% | 162.1% | 265.8% | 215.4% | 145.4% | 167.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −895K-74% | −1.3M-19% | −740K-78% | −1.1M-35% | −3.5M+14% | −1.6M-50% | −3.3M-49% | −1.7M-75% | −3.1M | −3.3M | −6.4M | −6.8M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | 18K | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | −6.4M | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −10.3M | –% | -1.11 | – |
| FY2024 | – | – | −11.6M | –% | -2.31 | – |
| FY2023 | – | – | −17.2M | –% | -6.00 | −20.5M |
| FY2022 | – | – | −24.3M | –% | -0.66 | −19.3M |
| FY2021 | – | – | −24.5M | –% | -0.68 | −26.6M |
| FY2020 | – | – | −31.8M | –% | -1.07 | −35.6M |
| FY2019 | – | – | −23.3M | –% | -1.06 | −11.7M |
| FY2018 | – | – | −13.9M | –% | -0.70 | −12.8M |